CRP and cancer: Furthermore, our findings suggest that from all the factors identified with COVID-19-related death, only haematological cancer type, a longer-established cancer diagnosis (2–5 years and >5 years), dyspnoea at the time of diagnosis and high levels of CRP were indicative of an early COVID-19-related death (within 7 days of diagnosis) in cancer patients.